Respiratory Diagnostic Test Kits Recalled for Decreased Performance Reliability
Qiagen's QIAstat-Dx Respiratory SARS-CoV-2 Panel diagnostic kits are recalled due to decreased performance reliability. Failed test runs could require sample retesting, potentially delaying diagnosis.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II medical device recall with identified performance reliability issues. No illnesses, injuries, or hospitalizations reported. The hazard is operational risk of delayed diagnosis from failed test runs, which is a risk-of-harm situation but lacks reported clinical consequences.
Plain-English summary
Qiagen GmbH is recalling 386 units of the QIAstat-Dx Respiratory SARS-CoV-2 Panel (REF 691223), an FDA-cleared qualitative test for analyzing nasopharyngeal swab samples from patients suspected of respiratory infection.
The FDA identified a decreased performance reliability rate in the recalled lots. The test kits may experience run abortions—failed test runs—which would require samples to be retested. This could delay diagnosis and patient care decisions.
The recalled kits are lot numbers 175010704 and 175011354, with expiration dates of 2023-10-06 and 2023-10-17. Affected products were distributed to healthcare facilities in DC, Alabama, California, Florida, Georgia, Maine, North Carolina, New York, Oregon, and Texas, as well as numerous international locations.
Facilities that have received these kits should discontinue use of the recalled lots and contact Qiagen for instructions regarding replacement products or refunds.
The recalled product
- Product
- QIAstat-Dx Respiratory SARS-CoV-2 Panel -US IVD qualitative test intended for analyzing nasopharyngeal swab (NPS) samples from patients suspected of respiratory infection for the presence of viral or bacterial nucleic acids REF 691223
- Manufacturer
- Qiagen GmbH
- Affected units
- 386
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- GTIN 14053228038846 LOT Numbers: 175010704
- 175011354 Exp. Date: 2023-10-06 and 2023-10-17
Distribution
Part of a larger recall action
This product is one of 2 recalled by Qiagen GmbH under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Qiagen GmbH
See all →- HighQiagen therascreen KRAS PCR Kit Handbook Error Could Cause False Negative Results
FDA (Devices) · 2023-10-11
- HighRespiratory diagnostic panel fails to produce test results
FDA (Devices) · 2023-08-02
- ModerateCOVID-19 Diagnostic Test Kits Recalled Due to Performance Reliability Issues
FDA (Devices) · 2023-08-02
- HighQiagen QIAamp DSP Virus Kit Recalled for Decreased Performance
FDA (Devices) · 2017-12-27
Same hazard · test failure
See all →- ModerateGSP Neonatal GALT Kit in vitro diagnostic test equipment
FDA (Devices) · 2026-07-15
- HighBioFire Spotfire Respiratory/Sore Throat Panel Recall for False Negatives
FDA (Devices) · 2026-05-13
- HighDiagnostic analyzer software may fail to alert users to expired reagents
FDA (Devices) · 2025-01-29
- ModerateBiocare Medical Recalls IHC Kits Due to Potential Staining Failure
FDA (Devices) · 2024-11-13
- HighCepheid Xpert Xpress Strep A test kits may produce invalid results
FDA (Devices) · 2023-11-08